Claris Advisors, LLC Pfizer Inc Transaction History

Claris Advisors, LLC

$196 Million
Q3 2024

A detailed history of Claris Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Claris Advisors, LLC holds 8,500 shares of PFE stock, worth $227,120. This represents 0.13% of its overall portfolio holdings.

Number of Shares

8,500

Holding current value

$227,120

% of portfolio

0.13%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$27.7 - $31.39 $235,450 - $266,815	8,500 New	8,500 $245,000
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $3,250 - $3,761	-90 Reduced 1.25%	7,089 $260,000
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $8,587 - $11,179	-218 Reduced 2.95%	7,179 $292,000
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $5,636 - $7,357	135 Added 1.86%	7,397 $379,000
Q3 2022 Nov 01, 2022	SELL	$43.76 - $53.42 $14,178 - $17,308	-324 Reduced 4.27%	7,262 $318,000
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $18,193 - $21,571	391 Added 5.43%	7,586 $398,000
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $86,787 - $107,540	-1,897 Reduced 20.86%	7,195 $372,000
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $375,681 - $556,885	9,092 New	9,092 $537,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.7 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.67 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.44 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.13 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claris Advisors, LLC , based on Form 13F filings with the SEC.

News

Stay updated on Claris Advisors, LLC with notifications on news.

Account